NeueHealth Inc. (NEUE)
NYSE NYSE Primary 
NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Encouraged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
Bronstein, Gewirtz & Grossman, LLC Encourages NeueHealth, Inc. (NEUE) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESSWIRE / December 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE: NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into NeueHealth, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into NeueHealth, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
NeueHealth Inc Is Being Investigated For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into NeueHealth, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / December 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in NeueHealth, Inc. ("NeueHealth" or "the Company") (NYSE:NEUE) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the NeueHealth board breached its fiduciary duties to shareholders.
NEUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into NeueHealth, Inc. and Encourages Investors to Contact the Firm
NEW YORK CITY, NY / ACCESSWIRE / December 24, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE) and New Enterprise Associates ("NEA") (: ). Investors who purchased NeueHealth and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NEUE.
NeueHealth to be taken private by New Enterprise Associates in $1.3 billion deal
Health insurer NeueHealth said on Monday that an affiliate of New Enterprise Associates and a consortium of investors would take it private at an enterprise value of about $1.3 billion.
NeueHealth, Inc. (NEUE) Q3 2024 Earnings Conference Call Transcript
NeueHealth, Inc. (NYSE:NEUE ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Emily Lombardi - Assistant Vice President Mike Mikan - President and CEO Jay Matushak - CFO Conference Call Participants Operator Ladies and gentlemen, welcome to the NeueHealth Third Quarter 2024 Earnings Call. My name is Kenneth, and I will be coordinating your call today.
NeueHealth (NEUE) Upgraded to Buy: What Does It Mean for the Stock?
NeueHealth (NEUE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
NeueHealth, Inc. (NEUE) Q2 2024 Earnings Call Transcript
NeueHealth, Inc. (NYSE:NEUE ) Q2 2024 Earnings Conference Call August 7, 2024 8:00 AM ET Company Participants Emily Lombardi - Investor Relations Mike Mikan - President & Chief Executive Officer Jay Matushak - Chief Financial Officer Conference Call Participants Operator Good morning, all. Welcome to the NeueHealth Q2 2024 Earnings Call.
